Skip to main content
    O

    OrganiGram Holdings Inc (OGI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.72
    -0.11 (-12.71%)

    Market Cap: $116.93M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OrganiGram Holdings Inc (OGI) Financials: Revenue, Profit and Cash Flow

    Updated Aug 11, 2026. Financial statements from company filings, amounts in CAD.

    OrganiGram Holdings reported revenue of CAD 186.09M for the fiscal year ended Sep 30, 2025, up 16.4% from the year before. That year, net income was CAD -17.78M with a net margin of -9.6%, operating cash flow was CAD -7.59M and free cash flow was CAD -24.64M. The quarter ended Jun 30, 2026 had revenue of CAD 105.78M and net income of CAD 105.54M.

    Revenue and Margins

    The operating margin was -34.1% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from CAD 6.13M, a compound annual rate of 46.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025186.09M+16.4%3.7%-34.1%-9.6%
    Sep 2024159.84M+7.1%29.7%-21.7%-28.4%
    Sep 2023149.21M+2.3%23.5%-162.7%-153.8%
    Sep 2022145.81M+84.2%21.7%-26.6%-9.8%
    Sep 202179.16M-8.8%-35.9%-92.0%-165.1%
    Sep 202086.80M+7.9%-65.1%-167.6%-156.9%
    Sep 201980.41M+547.0%60.3%6.8%-11.9%
    Sep 201812.43M+130.6%-215.4%293.0%165.0%
    Sep 20175.39M-12.1%-61.2%-206.0%-202.1%
    Sep 20166.13MN/A86.7%20.3%13.8%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue186.09M159.84M149.21M145.81M79.16M86.80M80.41M12.43M5.39M6.13M
    Cost of revenue179.26M112.32M114.13M114.24M107.56M143.28M31.94M-39.20M8.69M813.38K
    Gross profit6.83M47.52M35.07M31.57M-28.40M-56.49M48.47M-26.77M-3.30M5.31M
    Research and development10.95M11.20M12.19M5.96M3.65M1.27M409.00K000
    Operating income-63.41M-34.76M-242.74M-38.75M-72.84M-145.51M5.49M36.42M-11.10M1.25M
    Net income-17.78M-45.44M-229.48M-14.28M-130.70M-136.16M-9.54M20.51M-10.89M846.66K
    EBITDA-9.69M-22.68M-24.72M10.96MN/A-122.66M12.70M41.40M-8.99M2.07M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue105.78M59.79M63.49M80.06M70.79M65.60M42.73M44.70M41.06M37.63M36.45M46.04M
    Gross profit41.42M16.41M23.32M31.84M26.15M18.42M13.81M17.22M14.01M9.60M6.70M-12.75M
    Operating income5.33M-9.79M-3.42M1.19M-2.10M-7.58M-6.80M283.00K-5.05M-15.15M-15.93M-39.36M
    Net income105.54M-921.00K19.95M-37.96M-6.29M42.46M-22.96M-5.43M2.82M-27.07M-15.75M-32.99M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, cash and equivalents exceeded short-term debt of CAD 1.00M by 27.20M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets562.21M407.86M298.45M577.11M554.02M435.13M428.52M302.57M92.81M53.87M
    Current assets284.90M262.22M155.98M221.62M260.62M170.20M196.28M203.21M44.67M40.65M
    Cash and equivalents28.20M106.75M33.86M68.52M55.37M24.60M47.55M55.06M1.96M9.86M
    Total liabilities213.08M101.87M26.83M69.05M74.21M135.60M101.52M117.97M9.78M9.61M
    Short-term debt1.00M1.09M1.09M996.00K1.06M11.60M3.51M421.00K389.82K330.65K
    Long-term debtN/A25.00KN/A155.00K230.00K103.67M46.07M98.74M3.13M7.16M
    Shareholder equity349.13M305.99M271.62M508.06M479.81M299.53M327.01M184.59M83.03M44.26M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets820.26M522.66M530.67M562.21M564.62M537.90M479.21M407.86M354.75M331.78M299.01M298.45M
    Total liabilities263.74M149.89M161.22M213.08M179.12M147.34M155.56M101.87M58.89M59.98M41.19M26.83M
    Cash and equivalents10.85M54.08M7.58M28.20M35.88M13.18M44.30M106.75M79.26M71.80M41.81M33.86M
    Shareholder equity556.52M372.77M369.46M349.13M385.50M390.57M323.65M305.99M295.86M271.80M257.82M271.62M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Sep 2025.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow-7.59M3.87M-35.08M-36.21M-28.59M-45.13M-35.08M-12.70M-9.27M-1.77M
    Capital expenditures17.05M5.34M26.90M48.78M12.29M78.65M110.29M56.44M31.17M4.42M
    Free cash flow-24.64M-1.47M-61.98M-84.99M-40.88M-123.78M-145.38M-69.14M-40.44M-6.19M
    Investing cash flow-81.07M-30.80M1.35M44.03M-115.11M-138.20M-46.78M-98.00M-39.44M-27.15M
    Financing cash flow39.33M107.78M-814.42K5.33M174.46M160.37M74.33M163.91M40.81M37.31M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-4.30M-6.76M-16.01M-1.45M14.63M-16.59M-4.18M8.89M-3.73M-8.98M7.69M-15.96M
    Capital expenditures432.00K246.00K2.10M764.00K9.63M6.55M1.64M1.89M1.06M857.00K1.53M7.33M
    Free cash flow-4.73M-7.01M-18.12M-2.22M5.00M-23.14M-5.82M7.00M-4.79M-9.84M6.16M-23.30M
    Last 12 quarters

    Frequently Asked Questions About OGI

    What is OrganiGram Holdings' annual revenue?

    OrganiGram Holdings reported revenue of CAD 186.09M for the fiscal year ended Sep 30, 2025.

    How fast is OrganiGram Holdings' revenue growing?

    Revenue was up 16.4% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.5%.

    Is OrganiGram Holdings profitable?

    No. OrganiGram Holdings reported net income of CAD -17.78M for the fiscal year ended Sep 30, 2025, with a net margin of -9.6%.

    How much free cash flow does OGI generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of CAD -7.59M minus capital expenditures of CAD 17.05M produced free cash flow of CAD -24.64M.

    How much debt does OrganiGram Holdings have?

    The balance sheet dated Sep 30, 2025 reported short-term debt of CAD 1.00M and cash and equivalents of CAD 28.20M.